×

NLS Pharmaceutics Cash Flow Statement 2019-2023 | NLSP

Annual Data | Millions of US $ except per share data
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
$-12.172
$-16.496
$-11.946
$-2.861
$-5.447
$0.224
$0.911
$0.125
$-0.004
$0.385
$0.236
$0.99
$0.177
$0.068
$1.141
Change In Accounts Receivable
-
-
-
-
-
Change In Inventories
-
-
-
-
-
$2.26
$0.636
$-2.27
$1.497
$1.379
$-0.009
$0.991
$-0.897
$0.567
$2.738
$2.252
$1.627
$-3.167
$2.064
$4.117
$-9.685
$-13.879
$-14.936
$-0.729
$-0.19
Net Change In Intangible Assets
-
-
-
-
-
Net Acquisitions/Divestitures
-
-
-
-
-
Net Change In Short-term Investments
-
-
-
-
-
Net Change In Long-Term Investments
-
-
-
-
-
Net Change In Investments - Total
-
-
-
-
-
Investing Activities - Other
-
-
-
-
-
$1.634
-
$-1.371
$1.19
$0.668
-
$0.826
$-0.733
-
-
$1.634
$0.826
$-2.105
$1.19
$0.668
Total Common And Preferred Stock Dividends Paid
-
-
-
-
-
$1.634
$17.397
$20.338
$0.504
$0.408
$-8.051
$3.517
$5.338
$-0.127
$0.214
Common Stock Dividends Paid
-
-
-
-
-
www.jqwidgets.com